Guru Ownership Trend
Guru Analysis for Fate Therapeutics, Inc. (FATE)
Fate Therapeutics, Inc. (FATE), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $11.95 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $1.23 M net inflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 158.3%. Conversely, Steven Cohen reduced exposure by 97.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Fate Therapeutics, Inc. (FATE)
Major holders include Cliff Asness ($3.6 M), Renaissance Technologies (RenTech) ($3.57 M), Robert Bruce ($947,026). According to the latest reported data, 4 tracked investment managers collectively hold approximately 6.81 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.23 M, with 3 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited FATE. The total reported sell value was $1.78 M.
Yes, 0 managers opened new positions in FATE, and 3 increased their existing holdings. The total reported buy value was $3.02 M.